Pre-existing malignancy results in increased prevalence of distinct populations of CD4+ T cells during sepsis

Autor: Jennifer M. Robertson, Craig M. Coopersmith, Mandy L. Ford, Ching-Wen Chen, Jianfeng Xie, Wenxiao Zhang
Rok vydání: 2018
Předmět:
CD4-Positive T-Lymphocytes
Male
0301 basic medicine
Physiology
medicine.medical_treatment
lcsh:Medicine
Pathology and Laboratory Medicine
Memory T cells
Mice
White Blood Cells
Spectrum Analysis Techniques
Animal Cells
Neoplasms
Immune Physiology
Prevalence
Medicine and Health Sciences
lcsh:Science
Staining
Innate Immune System
education.field_of_study
Multidisciplinary
medicine.diagnostic_test
T Cells
Cell Staining
Animal Models
Flow Cytometry
3. Good health
Cytokine
medicine.anatomical_structure
Experimental Organism Systems
Spectrophotometry
Cytokines
Female
Tumor necrosis factor alpha
Cytophotometry
Cellular Types
Research Article
Death Rates
Immune Cells
T cell
Immunology
Population
Mouse Models
Biology
Research and Analysis Methods
Malignancy
Flow cytometry
Sepsis
03 medical and health sciences
Signs and Symptoms
Model Organisms
Population Metrics
Diagnostic Medicine
medicine
Animals
education
Blood Cells
Population Biology
lcsh:R
Biology and Life Sciences
Cancer
Cell Biology
Molecular Development
medicine.disease
030104 developmental biology
Specimen Preparation and Treatment
Case-Control Studies
Immune System
lcsh:Q
Developmental Biology
Zdroj: PLoS ONE, Vol 13, Iss 1, p e0191065 (2018)
PLoS ONE
ISSN: 1932-6203
Popis: The presence of pre-existing malignancy in murine hosts results in increased immune dysregulation and risk of mortality following a septic insult. Based on the known systemic immunologic changes that occur in cancer hosts, we hypothesized that the presence of pre-existing malignancy would result in phenotypic and functional changes in CD4+ T cell responses following sepsis. In order to conduct a non-biased, unsupervised analysis of phenotypic differences between CD4+ T cell compartments, cohorts of mice were injected with LLC1 tumor cells and tumors were allowed to grow for 3 weeks. These cancer hosts and age-matched non-cancer controls were then subjected to CLP. Splenocytes were harvested at 24h post CLP and flow cytometry and SPADE (Spanning-tree Progression Analysis of Density-normalized Events) were used to analyze populations of CD4+ cells most different between the two groups. Results indicated that relative to non-cancer controls, cancer mice contained more resting memory CD4+ T cells, more activated CD4+ effectors, and fewer naïve CD4+ T cells during sepsis, suggesting that the CD4+ T cell compartment in cancer septic hosts is one of increased activation and differentiation. Moreover, cancer septic animals exhibited expansion of two distinct subsets of CD4+ T cells relative to previously healthy septic controls. Specifically, we identified increases in both a PD-1hi population and a distinct 2B4hi BTLAhi LAG-3hi population in cancer septic animals. By combining phenotypic analysis of exhaustion markers with functional analysis of cytokine production, we found that PD-1+ CD4+ cells in cancer hosts failed to make any cytokines following CLP, while the 2B4+ PD-1lo cells in cancer mice secreted increased TNF during sepsis. In sum, the immunophenotypic landscape of cancer septic animals is characterized by both increased CD4+ T cell activation and exhaustion, findings that may underlie the observed increased mortality in mice with pre-existing malignancy following sepsis.
Databáze: OpenAIRE